Cargando…
Comparison of different gene-therapy methods to treat Leber hereditary optic neuropathy in a mouse model
INTRODUCTION: Therapies for Leber hereditary optic neuropathy (LHON), in common with all disorders caused by mutated mitochondrial DNA, are inadequate. We have developed two gene therapy strategies for the disease: mitochondrial-targeted and allotopic expressed and compared them in a mouse model of...
Autores principales: | Velmurugan, Sindhu, Chou, Tsung-Han, Eastwood, Jeremy D., Porciatti, Vittorio, Liu, Yuan, Hauswirth, William W., Guy, John, Yu, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083341/ https://www.ncbi.nlm.nih.gov/pubmed/37051151 http://dx.doi.org/10.3389/fnins.2023.1119724 |
Ejemplares similares
-
Longterm Reversal of Severe Visual Loss by Mitochondrial Gene Transfer in a Mouse Model of Leber Hereditary Optic Neuropathy
por: Yu, Hong, et al.
Publicado: (2018) -
The Relationship Between Stage of Leber's Hereditary Optic Neuropathy and Pattern Electroretinogram Latency
por: Porciatti, Vittorio, et al.
Publicado: (2022) -
Leber’s hereditary optic neuropathy companied with multiple-related diseases
por: Sun, Ming-ming, et al.
Publicado: (2022) -
Gene therapy restores mitochondrial function and protects retinal ganglion cells in optic neuropathy induced by a mito-targeted mutant ND1 gene
por: Liu, Yuan, et al.
Publicado: (2022) -
XIAP Protects Retinal Ganglion Cells in the Mutant ND4 Mouse Model of Leber Hereditary Optic Neuropathy
por: Wassmer, Sarah J., et al.
Publicado: (2020)